MARKER THERAPEUTICS, INC. Derivative Liability
MARKER THERAPEUTICS, INC. (MRKR) had Derivative Liability of $677.09 thousand as of 2012-12-31, per its 10-Q filed 2013-05-21.
Discontinued › Balance Sheet › Liabilities
us-gaap:DerivativeLiabilities · last filed 2013-05-21
- 2012-12-31: Derivative Liability $677.09K.
- 2012-09-30: Derivative Liability $871.86K.
- 2011-12-31: Derivative Liability $1.32M.
| Period end | Derivative Liability |
|---|---|
| 2012-12-31 | $677.09K 10-Q · filed 2013-05-21 |
| 2012-09-30 | $871.86K 10-Q · filed 2012-11-19 |
| 2011-12-31 | $1.32M 10-Q · filed 2012-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |